Moreover, elevated miR-26a levels have been demonstrated to reduce glucose-stimulated insulin secretion (GSIS), which helps to mitigate hyperinsulinemia—a key factor in both T2DM and obesity. The gene discussed is INS; the disease is hyperinsulinism.